Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Compass Therapeutics Inc (NASDAQ: CMPX) closed at $3.65 down -6.41% from its previous closing price of $3.90. In other words, the price has decreased by -$6.41 from its previous closing price. On the day, 1.55 million shares were traded. CMPX stock price reached its highest trading level at $4.08 during the session, while it also had its lowest trading level at $3.585.
Ratios:
For a deeper understanding of Compass Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 31.84 and its Current Ratio is at 31.84. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on December 23, 2024, initiated with a Buy rating and assigned the stock a target price of $32.
On November 15, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $5 to $4.
Ladenburg Thalmann Upgraded its Neutral to Buy on September 16, 2024, while the target price for the stock was maintained at $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 502199840 and an Enterprise Value of 373675488. For the stock, the TTM Price-to-Sale (P/S) ratio is 590.83 while its Price-to-Book (P/B) ratio in mrq is 3.63. Its current Enterprise Value per Revenue stands at 439.618 whereas that against EBITDA is -6.815.
Stock Price History:
The Beta on a monthly basis for CMPX is 0.97, which has changed by 1.4683545 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, CMPX has reached a high of $4.07, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 70.67%, while the 200-Day Moving Average is calculated to be 127.86%.
Shares Statistics:
For the past three months, CMPX has traded an average of 1.30M shares per day and 1513860 over the past ten days. A total of 137.59M shares are outstanding, with a floating share count of 83.22M. Insiders hold about 39.51% of the company’s shares, while institutions hold 43.53% stake in the company. Shares short for CMPX as of 1738281600 were 2748956 with a Short Ratio of 2.45, compared to 1735603200 on 2210789. Therefore, it implies a Short% of Shares Outstanding of 2748956 and a Short% of Float of 2.8199999.
Earnings Estimates
The stock of Compass Therapeutics Inc (CMPX) is currently in the spotlight, with 7.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.05 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.27 and -$0.39 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.38, with 7.0 analysts recommending between -$0.19 and -$0.68.
